Suit Says Abbott Conspired To Block Generic TriCor

Law360 (March 18, 2008, 12:00 AM EDT) -- Eighteen states and the District of Columbia have filed a lawsuit alleging that Abbott Laboratories and Fournier Industrie et Sante conspired to delay and prevent a generic version of their TriCor cholesterol drug from reaching the market by filing a series of frivolous patent infringement lawsuits.

The suit, which was filed Tuesday in the U.S. District Court for the District of Delaware, says that Abbott and its French partner brought a series of groundless patent lawsuits against generics companies, citing patents the two companies had obtained...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.